Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung Cancer
- 18 April 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (16), 1084-1090
- https://doi.org/10.1056/nejm199104183241603
Abstract
New prognostic factors are needed to guide the treatment of patients with non-small-cell lung cancer. We evaluated the prognostic value of altered expression of ABH blood-group antigens, which has been implicated in the multistep process of carcinogenesis and tumor progression.This publication has 15 references indexed in Scilit:
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate AntigensAdvances in Cancer Research, 1989
- ABH and Related Histo‐Blood Group Antigens; Immunochemical Differences in Carrier Isotypes and Their Distribution1Vox Sanguinis, 1989
- Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigensAPMIS, 1988
- Expression of A9 Antigen and Loss of Blood Group Antigens as Determinants of Survival in Patients with Head and Neck Squamous CarcinomaOtolaryngology -- Head and Neck Surgery, 1987
- A New International Staging System for Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1986
- The carbohydrate specificities of the monoclonal antibodies 29.1, 445 and 3C1B12 to the epidermal growth factor receptor of A431 cellsBioscience Reports, 1985
- The World Health Organization Histological Typing of Lung Tumours: Second EditionAmerican Journal of Clinical Pathology, 1982
- Early Immunologic Diagnosis and Prognosis of Carcinoma:Philip Levine Award AddressAmerican Journal of Clinical Pathology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Structural Representations of Tumor-Host Relationships in Mammary Carcinoma: Biologic and Prognostic SignificanceAmerican Journal of Clinical Pathology, 1956